Advisornet Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.43M | Sell |
27,109
-326
| -1% | -$43K | 0.16% | 118 |
|
|
2026
Q1 | $3.82M | Sell |
27,435
-1,083
| -4% | -$152K | 0.2% | 102 |
|
|
2025
Q4 | $3.5M | Sell |
28,518
-454
| -2% | -$55.2K | 0.19% | 104 |
|
|
2025
Q3 | $3.22M | Sell |
28,972
-525
| -2% | -$59.7K | 0.18% | 110 |
|
|
2025
Q2 | $3.27M | Sell |
29,497
-289
| -1% | -$30.8K | 0.21% | 104 |
|
|
2025
Q1 | $3.34M | Sell |
29,786
-935
| -3% | -$96.5K | 0.25% | 87 |
|
|
2024
Q4 | $2.84M | Sell |
30,721
-336
| -1% | -$30.3K | 0.24% | 93 |
|
|
2024
Q3 | $2.6M | Sell |
31,057
-3,048
| -9% | -$233K | 0.19% | 118 |
|
|
2024
Q2 | $2.34M | Sell |
34,105
-3,929
| -10% | -$262K | 0.21% | 111 |
|
|
2024
Q1 | $2.79M | Sell |
38,034
-16,701
| -31% | -$1.28M | 0.27% | 92 |
|
|
2023
Q4 | $4.43M | Buy |
54,735
+32
| +0.1% | +$2.49K | 0.41% | 53 |
|
|
2023
Q3 | $4.1M | Sell |
54,703
-2,571
| -4% | -$198K | 0.37% | 62 |
|
|
2023
Q2 | $4.41M | Buy |
57,274
+114
| +0.2% | +$9.09K | 0.38% | 67 |
|
|
2023
Q1 | $4.74M | Sell |
57,160
-320
| -0.6% | -$26.5K | 0.43% | 49 |
|
|
2022
Q4 | $4.93M | Sell |
57,480
-634
| -1% | -$50.2K | 0.49% | 45 |
|
|
2022
Q3 | $3.58M | Buy |
58,114
+431
| +0.7% | +$27.2K | 0.36% | 69 |
|
|
2022
Q2 | $3.56M | Sell |
57,683
-216
| -0.4% | -$13.4K | 0.35% | 75 |
|
|
2022
Q1 | $3.44M | Buy |
57,899
+11,462
| +25% | +$733K | 0.22% | 109 |
|
|
2021
Q4 | $3.37M | Buy |
46,437
+3,582
| +8% | +$247K | 0.21% | 112 |
|
|
2021
Q3 | $2.99M | Buy |
42,855
+644
| +2% | +$45.2K | 0.21% | 103 |
|
|
2021
Q2 | $2.91M | Buy |
42,211
+1,107
| +3% | +$73.9K | 0.19% | 119 |
|
|
2021
Q1 | $2.66M | Buy |
41,104
+2,571
| +7% | +$166K | 0.19% | 122 |
|
|
2020
Q4 | $2.25M | Sell |
38,533
-1,038
| -3% | -$62.6K | 0.18% | 120 |
|
|
2020
Q3 | $2.5M | Buy |
39,571
+15,101
| +62% | +$1.05M | 0.21% | 106 |
|
|
2020
Q2 | $1.88M | Buy |
24,470
+14,679
| +150% | +$1.12M | 0.15% | 140 |
|
|
2020
Q1 | $732K | Buy |
9,791
+3,033
| +45% | +$210K | 0.07% | 237 |
|
|
2019
Q4 | $439K | Sell |
6,758
-166
| -2% | -$10.8K | 0.04% | 354 |
|
|
2019
Q3 | $439K | Buy |
6,924
+652
| +10% | +$42.6K | 0.04% | 353 |
|
|
2019
Q2 | $424K | Sell |
6,272
-248
| -4% | -$16.3K | 0.05% | 322 |
|
|
2019
Q1 | $424K | Buy |
6,520
+177
| +3% | +$11.8K | 0.05% | 299 |
|
|
2018
Q4 | $397K | Sell |
6,343
-1,251
| -16% | -$87.4K | 0.05% | 277 |
|
|
2018
Q3 | $586K | Sell |
7,594
-556
| -7% | -$42K | 0.07% | 242 |
|
|
2018
Q2 | $577K | Sell |
8,150
-788
| -9% | -$55.6K | 0.08% | 215 |
|
|
2018
Q1 | $674K | Buy |
8,938
+641
| +8% | +$51K | 0.09% | 192 |
|
|
2017
Q4 | $594K | Buy |
+8,297
| New | +$630K | 0.09% | 183 |
|
Other funds holding GILD
LMFP
CIM
ATO
CGH
Advisornet Financial's GILD Position: Q2 2026 in Review
Advisornet Financial reduced its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, selling an estimated $43K and leaving 27,109 shares worth $3.43M. The position accounts for 0.16% of the portfolio, ranked #118.
Advisornet Financial first reported a position in GILD in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.93M in Q4 2022. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Advisornet Financial held 27,109 shares of Gilead Sciences worth $3.43M as of Q2 2026.
- Advisornet Financial sold 326 Gilead Sciences shares in Q2 2026, an estimated $43K.
- Gilead Sciences made up 0.16% of Advisornet Financial's portfolio in Q2 2026, its #118 holding.
- Advisornet Financial first reported a position in Gilead Sciences in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Gilead Sciences position peaked at $4.93M in Q4 2022.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.